Introduction
Phagocytosis is a primitive physiological activity manifested by many different kinds of cells. In the past decade, much information about the during ingestion by invagination and closure of the cell membrane (1, 2) . After ingestion, cytoplasmic granules, which are lysosomal structures containing digestive, oxidative, and antibacterial substances (3), rupture (4) and discharge their contents into the phagocytic vacuole (5, 6) , where digestion of the particles proceeds.
The metabolic alterations in polymorphonuclear leukocytes during phagocytosis include increased glycolysis and production of lactate, increased oxygen uptake, and increased production of CO2 by way of the hexose monophosphate shunt (7, 8) . To explain the biochemical basis for the burst of respiration, several workers have suggested an increased availability of NADP (9, 10) . The NADP would be produced during phagocytosis by activation of a pyridine nucleotide oxidase, acting on NADPH either directly or indirectly. Appropriate enzymes have been identified (10) (11) (12) , but the steps are not known by which the process of phagocytosis initiates increased oxidase activity.
The accumulation of toxic concentrations of lactic acid released from neutrophils has been suggested to cause local vascular and tissue injury (13) . Recently, a similar role has been proposed for released lysosomal enzymes (14, 15) . However, no direct pathogenetic relationship has been established between such mechanisms and the inflammatory response.
Recent xvork (16) has emphasized the anti-inflammatory effect of colchicine, a plant alkaloid used for centuries in the treatment of acute gouty arthritis. In studies with human polymorphonuclear leukocytes in vitro, colchicine interferes with locomotion (17) and with the response to a chemotactic stimulus (18) . Colchicine also partially inhibits some biochemical alterations associated with phagocytosis, including the increased production of C02 from the first carbon of glucose (19) , the release, by peroxidative uricolysis, of CO2 from the purine ring of added microcrystalline urate (19) , and the increased production of acid, presumably lactic acid (20) .
In the present study we have shown that colchicine diminishes the increased oxygen uptake usually associated with phagocytosis without interfering with phagocytosis itself. In addition, the formation of digestive vacuoles is impeded, and less acid phosphatase is released from granules. We suggest that these various alterations in the response of the cell to phagocytosis may explain one aspect of the suppression of gouty inflammation by colchicine.
Methods Solutions
Buffer. Krebs-Ringer phosphate buffer pH 7.4 (21), modified to contain one-fifth the suggested concentrations of CaCl2 and MgSO4 (to prevent precipitation), was sterilized by autoclaving the individual solutions at 15 pounds per square inch for 2 hours. For each experiment, heparin, 10 mg per 100 ml, was added. For suspending live streptococci, sterile bovine serum albumin,' 10 mg per 100 ml, was also added.
Dextran. A 3% solution of a dextran2 of mol wt 100,000 to 200,000 in normal saline was autoclaved for 2 hours and stored at 40 C.
Colchicine. Colchicine USP 8 was freshly prepared in buffer for each experiment, sterilized by passage through an ultrafine sintered glass filter, and added to incubation flasks in final concentrations of 2.5 X 10-mole per L, 2.5 X 10' mole per L, or 2.5 X 10' mole per L.
Glassware
All glassware was made sterile and pyrogen-free by heating at 1500 C for 2 hours. In addition, glassware used in the recovery and incubation of leukocytes (syringes, pipettes, centrifuge tubes, and Warburg flasks) was siliconized.
Leukocytes
Fifty to 110 ml of blood from the antecubital veins of normal volunteers was heparinized (10 mg per 100 ml), mixed with 2 vol of dextran solution, and allowed to stand at room temperature for 20 to 
Bacteria
An alpha-hemolytic streptococcus was obtained from a human throat culture; a coagulase-negative, hemolytic Staphylococcus albus was obtained from a finger abscess. Bacteria were kept on blood agar plates at 40 C and passed every 2 to 3 weeks. For a given experiment, the selected microorganism was cultured for 18 hours in beef heart infusion broth, centrifuged, and washed once in normal saline, and the bacterial cells were suspended in a small volume of buffer. The concentration of streptococci was estimated from a constructed curve of transmittance at 600 mg. The staphylococcal cells were boiled for 20 minutes before use.
Studies of respiration
Oxygen consumption was measured in flasks of approximately 15 ml vol, at 37.5°C for 2 hours or more, in a standard Warburg respirometer. The manometer joint for each flask was wiped with alcohol just before use, and a sterile cotton ball was inserted lightly into the joint. The center well held a filter paper fan and 0.2 ml of 15% potassium hydroxide to absorb CO2. The main compartment received 1 ml of the leukocyte suspension, 0.3 ml autologous serum, and 1.3 ml buffer with or without colchicine. The sidearm contained 0.2 ml of the suspension of streptococci or heat-killed staphylococci. After equilibration for 20 minutes, stopcocks were closed and manometer readings taken for approximately 1 hour. Then the contents of the sidearms were added to the main compartments, and incubation was continued, usually for an additional hour. Flasks were run in duplicate or triplicate. Standard controls in all experiments included one or two thermobarometers, and flasks in which buffer replaced suspensions of bacteria or leukocytes. Graphs were prepared by averaging the cumulative oxygen uptake of flasks in each experimental or control group and plotting these values against time.
Quantitation of phagocytosis and of intraleukocytic killing A modification of the method of Cohn and Morse (23) was used to enumerate total, supernatant, and cell-associated live bacteria in the flasks after incubation. For supernatant counts, the total flask contents, or 1 ml plus 4 ml of saline, were centrifuged at 700 rpm for 5 minutes at 00 C. The resultant supernatant was then gently transferred to a separate tube and mixed well, and samples, with or without 100-fold dilutions in normal saline, were mixed with agar in pour plates. For cell-associated bacterial counts, the cell button was suspended in 2 ml of buffer, subjected to 4 to 5 cycles of freezing and thawing in dry ice and acetone, and plated as above. In some experiments, total flask counts were estimated by similarly freeze-thawing the entire flask contents, or a 1: 10 dilution in buffer, before pour plates were made. Colonies of bacteria in the pour plates were counted after incubation at 37°C for 2 to 3 days. Also counted in each experiment were the bacterial inoculum, the contents of the thermobarometer, and the flasks containing bacteria without leukocytes. Other controls, in some experiments, included flasks that were identical to the experimental ones in contents, but were placed in a stationary incubator at 370 C instead of being agitated; the contents of still other flasks were removed after 1 hour of incubation, frozen and thawed three times in dry ice and acetone, and then incubated with streptococci.
In experiments with killed staphylococci, the bacteria were always grown in the same volume of nutrient medium. Live bacteria were plated and counted on one occasion.
Rate of phagocytosis.
Incubation of individual flasks was stopped by transfer to ice at 20, 40, or 60 minutes after the addition of streptococci to leukocytes. Supernatant and cell-associated bacteria were estimated in duplicate as described above. Average values were plotted on a logarithmic scale against time.
Thin preparations of leukocytes for morphology.
The method of Hirsch and Cohn (4) Determination of acid phosphatase.
At the time of enzyme assay, 0.2% saponin was added to duplicate or triplicate samples of 'both supernatant and granule fractions (3) . A modification of the method of Shinowara, Jones, and Reinhart (24) (described in the Bausch and Lomb Clinical Methods and Calibrations Manual) was used to measure acid phosphatase. Transmittance at 700 mg was determined on a Bausch and Lomb Spectronic-20 spectrophotometer. Timed readings were taken after the addition of aminonaphtholsulfonic acid. One or two phosphate standards were determined with each series. Total enzyme activity for each group was the sum of the activities of granule and supernatant fractions.
Results
The effect of colchicine on the respiration of phagocyting leukocytes A representative experiment is shown in Figure 1 . Flasks A through D contained leukocytes in serum-buffer, with or without colchicine in three different concentrations. Streptococci were tipped into the flasks at zero time. Flasks E contained leukocytes in serum-buffer and did not receive bacteria. Flasks F contained serum-buffer and streptococci, one flask with and one without colchicine, but both without leukocytes.
The increase in oxygen consumption that followed addition of bacteria to control leukocytes (A) was diminished in leukocytes incubated with colchicine (B, C, and D). In five other experiments of this design, the presence of colchicine was always associated with a decrease in the nor- mal respiratory burst. The oxygen consumption of leukocytes incubated with 2.5 x 10-4 M colchicine was consistently the least after addition of bacteria (as in Figure 1, D) . Leukocytes incubated with the two other concentrations of colchicine also had a diminished response to bacteria, compared with normal leukocytes (as in Figure 1 , B and C compared to A), but the values for the flasks with 2.5 X 105 M and 2.5 X 10-6 M colchicine were frequently not different from each other.
Colchicine had no consistent effect on the respiration of nonphagocyting leukocytes. The apparent depression of respiration during the first 40 minutes in the flasks containing 2.5 x 10-4 M colchicine (Figure 1, D) was usually not observed. In eight experiments, including the one shown in Figure 1 , the average respiration of leukocytes alone was 8 Al of 02 per hour, compared with 6 ul for leukocytes with 2.5 x 10-4 M colchicine. The respiration of the streptococci used was minimal (Figure 1, F) , with or without colchicine.
Colchicine, then, produces a dosage-dependent inhibition of the increased oxygen consumption that occurs when streptococci are added to leukocytes.
The effect of colchicine on phagocytosis
Reliability of the measurement of phagocytosis. Preliminary studies were required to ensure that phagocytosis was the only mechanism responsible for significant loss of bacteria during incubation. Accordingly, experiments were designed to determine whether streptococci were killed by human leukocytes (or their products) without phagocytosis, by human serum, or by colchicine itself.
The results of these studies appear in Table I. Leukocytes were incubated, with or without colchicine, for 1 hour. Then streptococci were added, and in the succeeding hour significant numbers of bacteria were lost (A and B). Bacteria were not lost if the streptococci were added to 1) only the supernatants from the first hour (C and D, flask supernatants), 2) the cell fractions from the first hour after resuspension and freeze-thawing (C and D, cells), 3) leukocyte suspensions that were frozen-thawed initially (E and F), and 4) serumbuffer without leukocytes (G and H). The pres- ence of colchicine did not affect the recovery of were lost in both preparations. Controls in this streptococci in any of these situations. study included flasks identical in content to the In additional controls (not shown in Table I ), experimental ones but placed in a stationary incucounts of leukocytes after incubation in Warburg bator. They showed no significant loss of bacflasks for 2 hours with and without colchicine teria during the incubation. This finding consti-(2.5 X 105 M) were within 5% of each other.
tutes another test of our experimental system (see Thus, under the conditions described, recovery also I Total bacteria per flask.
as described in Methods, except that to ensure uniformity we incubated cells for each group of triplicate flasks in 50-ml centrifuge tubes before addition of streptococci. There was no evidence of decreased phagocytosis by colchicine at 2.5 X 10-6, 2.5 x 10-5, or 2.5 x 10-4 mole per L. Recovered numbers of cell-associated bacteria at this ratio were not significant (< 100 per flask; not shown in Table II ).
In the next series of experiments, two of which are shown in Table III To determine whether an early effect of colchicine on phagocytosis might be present, numbers of supernatant and cell-associated bacteria were counted at 20-minute intervals after addition of streptococci. A representative experiment is shown in Figure 2 . There was still no consistent difference between preparations with and without colchicine.5 4 When very large numbers of bacteria (> 3 X 10W) were incubated in this system, frequently about 20%o of the inoculum could not be recovered in the control flasks after 2 hours of incubation. The presence of colchicine did not affect the numbers of bacteria recovered. 5 Frequently, as in Figure 2 , the final supernatant counts in the flasks with colchicine were lower than in those without, suggesting a slightly increased phagocytosis. The same result can be observed in Tables II and  III . This difference, however, was usually negligible in terms of the total bacteria phagocyted in each flask. For example, in Figure 2 , the values are 2.36 X 10' vs. 2.27 X 108, a difference of less than 4%.
Thus, although colchicine, in concentrations as low as 2.5 X 10-6 mole per L, produces a dosagedependent inhibition of the respiratory burst that normally accompanies phagocytosis (Figure 1) , there is no evidence of a decrease in phagocytosis per se with concentrations of colchicine 100 times as great (Table II) . In an attempt to explain the metabolic alteration, we examined the morphology of incubated leukocytes.
The effect of colchicine on the granules of polymorphonuclear leukocytes Morphologic observations (Figures 3 and 4) . leukocytes were present. Duplicate samples were taken from single flasks at timed intervals and the average bacterial counts plotted on a logarithmic scale against time.
The values for streptococci are average results from two flasks as described in Figure 1 . In additional controls, the contents of two flasks, one with and one without colchicine, were frozen-thawed three times after the first hour of incubation and before the streptococci were added. granules ( Figure 3A) . Samples of the same cells incubated for 1 hour with colchicine (2.5 x 10-5 M) were similar in appearance (not shown in Figure 3 ). After phagocytosis of staphylococci, control neutrophils showed the expected loss of granules and appearance of large digestive vacuoles, many containing bacteria ( Figure 3B and C) . In contrast, cells treated before phagocytosis with colchicine (2.5 x 10-5 M) showed numerous intracellular bacteria but notably less degranulation and vacuolization ( Figure 3D and E). Although the numbers of granules are not clearly evident in the photomicrographs, the cytoplasmic density correlates with the numbers of intact granules. Similar experiments were done with live streptococci as the ingested particles (Figure 4) . Again, the control polymorphonuclear leukocytes showed more extensive degranulation and vacuolization after phagocytosis than did the leukocytes incubated with colchicine (2.5 x 10-5 M).
In both experiments, numbers of intracellular bac-FIG. 4 teria appeared similar in control and colchicinetreated leukocytes.
Thus, colchicine appears to interfere in polymorphonuclear leukocytes with the degranulation and vacuolization that normally follow phagocytosis.
Enzymne assay. To confirm our microscopic impression, we used granule-associated acid phosphatase activity as a measure of the degree of degranulation. Standard incubations were carried out, and then enzyme assays were done on cell supernatant and granule fractions (see Methods). No acid phosphatase activity could be detected in the heat-killed staphylococci used in all experiments.
The total (granule plus supernatant) enzyme activity in all leukocyte preparations decreased after 1 hour of phagocytosis ( Figure 5 ). Though not observed after 30 minutes of phagocytosis in a study using rabbit leukocytes (26) , this finding was consistent in our experiments. Therefore, to determine per cent granule-associated enzyme activities, we compared the activity in each granule fraction with the total activity in nonphagocyting control cells.
The results of seven experiments are averaged in Figure 6 . In cells incubated for 1 hour without colchicine and for the additional hour without bacteria, the granule-associated enzyme activity was 78%o of the total. If bacteria were added for the second hour, the granule-associated activity dropped to 38%. If, however, colchicine was added for the first hour and bacteria were added for the second hour, granule-associated enzyme activity fell only from 78% to 50%. In a control not shown in Figure 6 , cells incubated with or without colchicine for 1 hour had the same granule-associated enzyme activities.
Measurements of granule-associated acid phosphatase activity therefore support the morphologic observations that colchicine-treated leukocytes do not degranulate after phagocytosis as much as control leukocytes.
Discussion
Incubation of leukocytes with colchicine produced a dosage-dependent inhibition of the increased oxygen uptake that normally accompanies phagocytosis. Although phagocytosis was not altered, it was associated with less degranulation and vacuolization of the phagocytic cell. The magnitude of the "metabolic burst," then, at least in this system, is not a proper measure of the extent of phagocytosis.
A more likely hypothesis is that the metabolic activity is related to alterations in granule structure (27) . By maintaining granular integrity, cochicine could keep a granule-associated oxidative enzyrie (10) (11) (12) from its soluble substrate. Recent evidence (28) , however, suggests that an oxidase for NADH is predominantly located in the nongranular fraction of the cell. This would suggest that. if metabolic changes and granule lysis are indeed closely related, a more complex sequence of events must be involved. Since the exact stimulus for metabolic alterations in the cell is unknown, any action of colchicine on granules need not be direct. Indeed, in preliminary studies with isolated granule fractions (not reported here), colchicine did not appear to inhibit the release of acid phosphatase activity by saponin.
In the present studies there were no consistent effects of colchicine on the resting cell; the effects were seen only when the cell was ingesting particles. Furthermore, the modest metabolic activity and degranulation that occurred with colchicine treatment may not be "abnormal" for the cell under all conditions of ingestion. For instance, using guinea pig exudate leukocytes and polystyrene spherules of very small diameter (0.088 /u), Roberts and Quastel (29) estimated the degree of phagocytosis at 24,000 particles per leukocyte, whereas the oxygen uptake was similar to that of resting cells. The relation of particle size and number to the magnitude of the metabolic change has been reported by others (30, 31) . Perhaps small particles are normally ingested without the dramatic (Figures 3B and C, and 4A) and sometimes self-destructive changes that are seen with phagocytosis of larger particles. By tending to uncouple phagocytosis of large particles from the usual associated events, colchicine may allow the cell to behave as though it were ingesting smaller or fewer particles.
The present work does not indicate a primary site of action for colchicine. Colchicine has been proposed to interfere with the cellular organization of labile, fibrillar systems concerned with structure and movement (32) . In this way it is thought to interfere with the motility of polymorphonuclear leukocytes (17, 18) , cells in which continual reversible cytoplasmic structural changes are required for amoeboid activities. Since such organized systems have not yet been defined ultrastructurally in granulocytes, a discussion of their possible relationship to the dissociative effects of colchicine in the present studies would be premature. 6 The present work does, however, suggest a 6 Since this paper was submitted, microtubular elements have been demonstrated in mature, human polymorphonuclear leukocytes (33) . These organelles were not found in colchicine-treated cells.
mechanism by which colchicine might suppress inflammation. First, some observations aimed at elucidating the pathogenesis of acute gouty arthritis may be pertinent: a) Sodium urate crystals are very frequently present in the synovial fluid of gouty patients (34) . b) Intra-articular or subcutaneous injections of crystals of similar size (0.5 to 8 k in length) in gouty and nongouty patients and in dogs result in an inflammatory reaction (35, 36) . c) In the synovial fluid, during both spontaneous acute attacks and those induced by injected crystals, there are leukocytosis and phagocytosis of crystals (35, 37) . d) The same weight of much smaller urate crystals (0.03 to 0.04 u) produces little or no inflammation (35) . e) Colchicine cures acute attacks, spontaneous or induced (35) . f) Pretreatment with colchicine decreases the frequency of acute gouty attacks (38) and decreases the magnitude of crystal-induced inflammation (16) .
With these points in mind, Seegmiller and Howell (39) have suggested that metabolic products of the inflammatory response may favor continued precipitation of urate from supersaturated body fluids, and may thus allow the propagation of a vicious cycle of crystallization, leukocytosis, phagocytosis, and increased metabolic activity. From the current studies, colchicine would appear both to impede the accumulation of possible toxic metabolic products (by decreasing activity of the hexose monophosphate shunt) and to maintain the integrity of lysosomal structures. Both these effects may reduce tissue injury and subsequent inflammation, thus perhaps accounting for one anti-inflammatory effect of colchicine in acute gouty arthritis.
Finally, the "metabolic burst" should not be viewed in too strict a setting: it occurs in mononuclear phagocytes, the particular pattern apparently reflecting cell type, location, and/or maturation (40) ; it can occur in polymorphonuclear leukocytes that are not ingesting particles (41, 42) . In such stimulated cells, the use of colchicine may aid in analyzing primary dependencies among morphologic, enzymic, and metabolic changes.
